Overview

Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants

Status:
Completed

Trial end date:
2005-09-01

Target enrollment:
0

Participant gender:
All

Summary

This is a multi-center, randomized, double-masked, controlled study to evaluate the safety and efficacy of fluocinolone acetonide (FA) intravitreal implants for the management of subjects with non-infectious uveitis affecting the posterior segment of the eye. An additional objective is to compare the safety and efficacy of two doses of fluocinolone acetonide.

Phase:

Phase 2/Phase 3

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Bausch & Lomb Incorporated

Treatments:

Fluocinolone Acetonide

Criteria

Inclusion Criteria:

- Males or non-pregnant females at least 6 years of age who had been diagnosed and
treated for recurrent, non-infectious uveitis affecting the posterior segment of one
or both eyes for at least 1 year prior to the start of the study, and had 'quiet' eyes
at surgery

Exclusion Criteria:

- Coexisting medical or ocular conditions that would interfere with the study results